NCT04943861

Brief Summary

The objectives of this study are to better understand how FI (food insecurities) contributes to the development of cardiometabolic comorbidities among PWH (People with HIV) and to test a novel bilingual FI intervention designed to reduce these comorbidities among food insecure PWH. The PI and staff will conduct this study in partnership with the Wake Forest Infectious Diseases Specialty Clinic, one of the largest Ryan White-funded clinics in North Carolina, which serves more than 2,000 PWH annually from a predominantly rural catchment area that includes South Central Appalachia. This area has high rates of both FI and HIV.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
10mo left

Started Dec 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Dec 2023Feb 2027

First Submitted

Initial submission to the registry

June 22, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 29, 2021

Completed
2.4 years until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2027

Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

3.2 years

First QC Date

June 22, 2021

Last Update Submit

February 24, 2026

Conditions

Keywords

Food Insecurity

Outcome Measures

Primary Outcomes (4)

  • Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) scores

    Healthy Range: 1.0 (0.5-1.4) - Less than 1.0 means you are insulin-sensitive which is optimal. Above 1.9 indicates early insulin resistance

    Baseline

  • Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) scores

    Healthy Range: 1.0 (0.5-1.4) - Less than 1.0 means you are insulin-sensitive which is optimal. Above 1.9 indicates early insulin resistance

    Month 12

  • Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) scores

    Healthy Range: 1.0 (0.5-1.4) - Less than 1.0 means you are insulin-sensitive which is optimal. Above 1.9 indicates early insulin resistance

    Month 24

  • Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) scores

    Healthy Range: 1.0 (0.5-1.4) - Less than 1.0 means you are insulin-sensitive which is optimal. Above 1.9 indicates early insulin resistance

    Month 36

Study Arms (2)

weCare/Secure

ACTIVE COMPARATOR

The weCare intervention is based on the social cognitive and empowerment theories and social support and is currently designed to reduce missed HIV care appointments and increase viral suppression among PWH who are newly diagnosed or out of care through the use of peer navigation and mHealth

Behavioral: weCare/Secure

Usual Care

OTHER

There is no peer navigation within usual care.

Other: Usual Care

Interventions

weCare/SecureBEHAVIORAL

The weCare intervention is based on the social cognitive and empowerment theories and social support and is currently designed to reduce missed HIV care appointments and increase viral suppression among PWH who are newly diagnosed or out of care through the use of peer navigation and mHealth

weCare/Secure

There is no peer navigation within usual care.

Usual Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • participant must be a patient of the Wake Forest Infectious Diseases Specialty Clinic
  • be living with HIV
  • ≥18 years of age
  • provide informed consent

You may not qualify if:

  • unable to speak English or Spanish
  • have cognitive impairment that would prevent participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest Health Sciences

Winston-Salem, North Carolina, 27157, United States

RECRUITING

Related Publications (1)

  • Tanner AE, Palakshappa D, Morse CG, Mann-Jackson L, Alonzo J, Garcia M, Wright E, Dharod A, Isom S, Sucaldito AD, Aviles LR, Rhodes SD. Exploring the consequences of food insecurity and harnessing the power of peer navigation and mHealth to reduce food insecurity and cardiometabolic comorbidities among persons with HIV: protocol for development and implementation trial of weCare/Secure. Trials. 2022 Dec 12;23(1):998. doi: 10.1186/s13063-022-06924-3.

MeSH Terms

Conditions

Prediabetic StateDiabetes Mellitus, Type 2

Interventions

Secure resin cement

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Scott D Rhodes, PhD

    Wake Forest Health Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2021

First Posted

June 29, 2021

Study Start

December 1, 2023

Primary Completion (Estimated)

February 28, 2027

Study Completion (Estimated)

February 28, 2027

Last Updated

February 25, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Sharing data generated from this study is an essential part of our proposed activities. This study will generate both quantitative and qualitative data

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Last 6 months of Year 5
Access Criteria
De-identified data and associated documentation (including codebooks) will be available from the Principal Investigators under a data-sharing agreement with users that provides for a commitment to: (1) using the data for research purposes; (2) securing the data using appropriate computer technology; and (3) to destroying or returning the data after analyses are completed

Locations